Stockreport

NeuBase Therapeutics Hosting Key Opinion Leader Meeting on Huntington's Disease and PATrOL™-Enabled Therapy on September 16th

NeuBase Therapeutics, Inc.  (NBSE) 
Last neubase therapeutics, inc. earnings: 3/26 04:05 pm Check Earnings Report
PDF PITTSBURGH, Sept. 09, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing next-generati [Read more]